Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07188337

Characteristics of Diabetic Foot Ulcer Patients

This study examines the demographic, clinical, and laboratory characteristics of patients with diabetic foot ulcers admitted to 5 Azar Hospital, Gorgan, in 2024. By analyzing factors such as Hb, WBC, HbA1C, ESR, and CRP in relation to ulcer severity, the study aims to identify predictors of outcomes and support more effective prevention and management strategies

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabetic Foot Ulcer Cardiovascular Diseases Diabetes Complications Diabetes Mellitus Diabetic Angiopathies Diabetic Foot Diabetic Neuropathies Endocrine System Diseases Foot Ulcer Glucose Metabolism Disorders Leg Ulcer Metabolic Diseases Nutritional and Metabolic Diseases Skin Diseases Skin Ulcer Skin and Connective Tissue Diseases Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

5Th Azar Medical Center

Gorgan, Outside of the US, 4917956808, Iran

Location status: Recruiting

Location contact

Pezhman Kharazm, MD

CONTACT

[email protected]

09111751861 ext. 0098

About this study

Diabetic foot ulcer (DFU) is one of the most serious and preventable complications in diabetic patients, often leading to infection, hospitalization, lower limb amputation, and increased mortality. This cross-sectional descriptive-analytical study aims to investigate the demographic, clinical, and laboratory characteristics of approximately 200 patients with DFU admitted to 5 Azar Hospital, Gorgan, in 2024. Data will be retrospectively collected from medical records after obtaining ethical approval.

The study will analyze relationships between patient demographics, clinical features, and laboratory findings (including Hb, WBC, HbA1C, ESR, CRP) with ulcer severity based on Wagner's classification. Statistical tests such as independent t-test, chi-square, Fisher's exact test, and multivariable logistic regression will be used.

By identifying key factors associated with ulcer severity and outcomes, the findings of this study may contribute to more effective prevention and management strategies for diabetic foot ulcers, ultimately reducing complications and healthcare costs

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted to 5 Azar Hospital, Gorgan, in 2024
  • Diagnosis of diabetic foot ulcer (DFU) confirmed by medical records
  • Complete demographic, clinical, and laboratory data available in medical files

Exclusion criteria

  • Incomplete or missing medical records
  • Patients with foot ulcers of non-diabetic etiology
  • Patients whose key laboratory data are unavailable

Treatment and study plan

Primary outcomes

  1. Severity of diabetic foot ulcer (measured by Wagner classification at admission)

    Time frame: Baseline

    Measured by Wagner classification

  2. Laboratory parameters and ulcer grade

    Time frame: Baseline

    Association between Hb, WBC, HbA1C, ESR, and CRP levels with Wagner ulcer grade

Secondary outcomes

  1. Duration of diabetes until ulcer onset

    Time frame: Baseline

    Time (in years) between diabetes diagnosis and first DFU occurrence

  2. Smoking status and ulcer severity

    Time frame: Baseline

    Correlation between smoking history (yes/no) and Wagner ulcer grade

  3. Treatment outcomes

    Time frame: At hospital discharge (average of 10 days)

    Frequency of outcomes: antibiotic therapy, wound debridement, or amputation

  4. Ulcer recurrence

    Time frame: During 12-month follow-up (based on records)

    Number of hospital readmissions due to DFU.

  5. Demographic distribution

    Time frame: Baseline

    Age, sex, occupation, and ethnicity of DFU patients

Study contacts

Contact information is provided by the study sponsor or research team.

Pezhman Kharazm

CONTACT

[email protected]

09111751861

Sponsors and collaborators

Lead sponsor

Golestan University of Medical sciences

Other

Registry information

Official study title

Examining the Demographic, Clinical, and Laboratory Data of Patients With Diabetic Foot Ulcers Admitted to 5 Azar Hospital in 2024 (Registry Project)

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 23, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.